TABLE 2.
No. of Mice Relapsing after Treatment % (Proportion)
|
|||
---|---|---|---|
Treatment Group* | 8 wk | 10 wk | 12 wk |
Daily | |||
R10HZ 5/7 | — | — | 100 (15/15) |
P7.5HZ 5/7 | — | 60 (9/15) | 0 (0/15) |
P10HZ 5/7 | 67 (10/15) | 0 (0/15) | 0 (0/15) |
P10MZ 5/7 | 27 (4/15) | 0 (0/15) | — |
Thrice-weekly | |||
R10HZ 3/7 | — | — | — |
P10HZ 3/7 | — | 87 (13/15) | 33 (5/15) |
P15HZ 3/7 | — | 53 (8/15) | 0 (0/15) |
P20HZ 3/7 | — | 7 (1/15) | 0 (0/15) |
P15MZ 3/7 | — | 7 (1/15) | 0 (0/15) |
See Table 1 for definition of abbreviations.
Z administered for the first 2 months of therapy only.